This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/chemspider/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02563/identifier/kegg-compound/

Statements

Subject Item
n2:DB02563
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB02563 n8:DB02563
dcterms:title
Hexanoyl-Coenzyme A
adms:identifier
n10:3479 n11:DB02563 n12:27540 n13:46936426 n14:46507427 n15:C05270 n16:HXC
n3:IUPAC-Name
n4:271B4313-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4319-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4318-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4315-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4316-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4317-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4311-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4312-363D-11E5-9242-09173F13E4C5 n4:271B430F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4310-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B431F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4320-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B431A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B431B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B431D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B431C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B431E-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
5060-32-2
n3:Bioavailability
n4:271B4325-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4327-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4328-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4324-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4323-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4326-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4314-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4321-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4322-363D-11E5-9242-09173F13E4C5